Close
  Indian J Med Microbiol
 

Figure 3: Primary end point: Mean percent change from baseline in BMD in lumbar spine (ITTE population) *Mean treatment difference (95% confidence interval [CI]) and P-value at six months based on ANCOVA. Error bars are 95% CIs from the model % change = treatment + baseline BMD. Denosumab group: n = 100; placebo group: n = 105. ANCOVA: Analysis of covariance; BMD: bone mineral density; ITTE: intent-to-treat efficacy

Figure 3: Primary end point: Mean percent change from baseline in BMD in lumbar spine (ITTE population) *Mean treatment difference (95% confidence interval [CI]) and <i>P</i>-value at six months based on ANCOVA. Error bars are 95% CIs from the model % change = treatment + baseline BMD. Denosumab group: <i>n</i> = 100; placebo group: <i>n</i> = 105. ANCOVA: Analysis of covariance; BMD: bone mineral density; ITTE: intent-to-treat efficacy